Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
162.72
-0.96 (-0.59%)
Jan 13, 2026, 3:40 PM EST - Market open
Jazz Pharmaceuticals (JAZZ) Oncology Revenue Breakdown
History
| Date | Rylaze Enrylaze | Zepzelca | Defitellio Defibtrotide | Vyxeos | Erwinaze |
|---|---|---|---|---|---|
| Sep 30, 2025 | 396.25M | 295.20M | 198.17M | 165.23M | 146.10M |
| Jun 30, 2025 | 395.16M | 301.75M | 212.24M | 161.96M | 150.47M |
| Mar 31, 2025 | 402.33M | 308.25M | 209.55M | 160.12M | 147.14M |
| Dec 31, 2024 | 410.85M | 320.32M | 216.57M | 162.60M | - |
| Sep 30, 2024 | 411.11M | 316.00M | 210.00M | 156.26M | - |
| Jun 30, 2024 | 417.19M | 308.15M | 191.91M | 151.77M | - |
| Mar 31, 2024 | 411.05M | 297.45M | 192.60M | 142.82M | - |
| Dec 31, 2023 | 394.23M | 289.53M | 184.00M | 147.50M | - |
| Sep 30, 2023 | 373.45M | 287.49M | 173.57M | 130.85M | - |
| Jun 30, 2023 | 342.11M | 279.82M | 175.29M | 131.09M | - |
| Mar 31, 2023 | 313.37M | 277.76M | 183.88M | 130.92M | - |
| Dec 31, 2022 | 281.66M | 269.91M | 194.29M | 127.98M | - |
| Sep 30, 2022 | 265.64M | 262.78M | 196.15M | 132.48M | - |
| Jun 30, 2022 | 212.80M | 264.17M | 204.40M | 137.10M | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.